Advertisement
Canada markets open in 4 hours 57 minutes
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7270
    +0.0006 (+0.09%)
     
  • CRUDE OIL

    82.32
    -0.37 (-0.45%)
     
  • Bitcoin CAD

    84,096.65
    -3,382.99 (-3.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,394.90
    +6.50 (+0.27%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,716.75
    +58.25 (+0.33%)
     
  • VOLATILITY

    18.02
    -0.19 (-1.05%)
     
  • FTSE

    7,884.19
    +36.20 (+0.46%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6806
    +0.0004 (+0.06%)
     

Healthcare Trust of America (HTA) Q1 FFO Lag Estimates

Healthcare Trust of America (HTA) came out with quarterly funds from operations (FFO) of $0.44 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to FFO of $0.44 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an FFO surprise of -2.22%. A quarter ago, it was expected that this medical office building real estate investment trust would post FFO of $0.45 per share when it actually produced FFO of $0.43, delivering a surprise of -4.44%.

Over the last four quarters, the company has not been able to surpass consensus FFO estimates.

Healthcare Trust of America , which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $202 million for the quarter ended March 2022, surpassing the Zacks Consensus Estimate by 1.67%. This compares to year-ago revenues of $191.49 million. The company has topped consensus revenue estimates two times over the last four quarters.

ADVERTISEMENT

The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.

Healthcare Trust of America shares have lost about 11.9% since the beginning of the year versus the S&P 500's decline of -9.8%.

What's Next for Healthcare Trust of America?

While Healthcare Trust of America has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Healthcare Trust of America: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus FFO estimate is $0.45 on $199.7 million in revenues for the coming quarter and $1.81 on $803.6 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Other is currently in the bottom 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the broader Zacks Finance sector, Metromile, Inc. (MILE), has yet to report results for the quarter ended March 2022.

This company is expected to post quarterly loss of $0.10 per share in its upcoming report, which represents a year-over-year change of +92.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Metromile, Inc.'s revenues are expected to be $11.6 million, down 32.9% from the year-ago quarter.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Healthcare Trust of America, Inc. (HTA) : Free Stock Analysis Report
 
Metromile, Inc. (MILE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research